Developer docs
API playgroundTry for free, no card

Search company profiles

Cogvio

Full company profile

uuid000bav6

Namestring
Cogvio
Legal namestring
Cogvio, s.r.o.
Websiteurl
cogvio.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Cogvio (legal entity Cogvio, s.r.o.) is a Prague-headquartered technology and data science company that develops SaaS products and provides consulting services to the pharmaceutical and healthcare industries. It operates as a wholly-owned subsidiary of IQVIA (NYSE:IQV) and is commercially positioned as 'COGVIO, an IQVIA business.' The company's product portfolio is built around three core SaaS tools: Price Monitor, an AI-powered platform that continuously integrates pricing, reimbursement and health technology assessment (HTA) data from more than 100 global sources to support market access, payer negotiations and lifecycle price management; Market Access Monitor, which tracks market access conditions across geographies; and Market Intelligence Tool, which provides competitive and market intelligence for pharma decision-makers. Underlying technology uses AI-powered algorithms for automatic data extraction, predictive analytics, optimization of launch and pricing strategies, and anomaly detection for price erosion control, complemented by custom analytics, real-world evidence (RWE) work, and integration with client data warehouses and BI systems.

Cogvio's commercial model combines annual subscription-based SaaS access to Price Monitor, Market Access Monitor and Market Intelligence Tool with a professional services arm that delivers custom consulting, audits, IT technology assessment, and GAMP/GDPR/HIPAA-compliant healthcare software development. Go-to-market is enterprise field sales targeting market access and pricing teams at large pharmaceutical companies; pricing is quote-based with no public tiers, and products are accessed via authenticated portals (pricemonitor.cogvio.com, login.cogvio.com, mit.cogvio.com). The named customer base includes seven top-tier pharmaceutical companies — AbbVie, Amgen, Biogen, Boehringer Ingelheim, MSD, Novartis and Pfizer — alongside a secondary healthcare IT segment serving hospitals and other organizations needing regulatory-compliant software. Cogvio was founded in 2017 by Pavel Svítil (CEO), Tomáš Doležal (Chief Knowledge Officer) and Petr Bartoš (CTO), combines deep regulatory, medical, pharmacoeconomics and software expertise, and is currently sized at 11-50 employees operating globally with particular concentration in Europe.

Short descriptiontext

Cogvio, an IQVIA business, is a Prague-based SaaS and consulting provider that builds AI-powered pricing, market access and market intelligence tools for large pharmaceutical companies, serving clients such as AbbVie, Amgen, Biogen, Boehringer Ingelheim, MSD, Novartis and Pfizer.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPrague, Czechia
HQ citystring
Prague
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical pricing analytics, market access intelligence, drug reimbursement data, pharma SaaS platform, healthcare data integration
Industry4 codes
PRIMARYHLAIAKAK
Pricing Operations & Analytics (Price Governance, Systems, Reporting)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIAKAF
International Reference Pricing (IRP) & External Price Benchmarking
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIAKAA
Pricing & Contracting Strategy
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Pharmaceutical Market Access & Pricing Analytics
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Software Products (SaaS)
TypeSubscription Recurring
Description

Subscription-based access to AI-powered software tools including Price Monitor, Market Access Monitor, and Market Intelligence Tool. These platforms provide continuous insights and analytics for pharmaceutical pricing and market access teams.

cogvio.com
2Professional Services & Consulting
TypeProfessional Services
Description

Custom consulting projects including tailor-made solutions, audits, IT technology assessment, and software development for pharma and healthcare clients. Cooperation model described as 'Be a partner, not a client.'

cogvio.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise pricing via direct inquiry
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing tiers listed. Contact/demo-based sales approach for market access and pricing teams in pharmaceutical companies.

cogvio.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Price Monitor
Description

AI-powered digital tool that integrates 100+ global sources of pricing/reimbursement/HTA data and provides market access and pricing insights for pharmaceutical companies.

cogvio.com
+2 more records
Core offering1 text field

Cogvio develops and sells AI-powered SaaS platforms—primarily Price Monitor—that aggregate over 100 global sources of drug pricing, reimbursement, and HTA data to deliver market access and pricing insights to pharmaceutical companies. Its offering is complemented by Market Access Monitor and Market Intelligence Tool, plus consulting and custom data analysis services for pharma and healthcare clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • AI-powered engine continuously integrating 100+ global data sources
Product overview1 text field

COGVIO, an IQVIA business, is a technology start-up developing specialized software products and providing consulting to the pharma industry. The product portfolio centers on three main digital tools: Price Monitor (AI-powered pricing/reimbursement data platform integrating 100+ global sources), Market Access Monitor (market access monitoring), and Market Intelligence Tool (market intelligence). These are complemented by consulting services including drug pricing & market access strategies, advanced data analysis (custom projects, RWE analysis, data integration), and pharma/healthcare software development & compliance services.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Digital health platform providing market access, affordability, and physician-engagement solutions to pharma. Comparable in targeting pharma market access teams with software-based solutions, though more focused on patient affordability.

TypeBroad incumbent
Description

Dominant cloud platform vendor for pharma commercial and R&D workflows, including CRM and data products. Adjacent/competing for the same market access and pricing IT wallet with broader product breadth.

3ZS Associates
TypeDirect peer
Description

Management consulting and analytics firm serving pharma with pricing, market access, and AI-driven commercial solutions. Comparable to Cogvio in domain specialization, enterprise pharma customers, and analytics-plus-services model.

TypeBroad incumbent
Description

Parent company and global leader in healthcare intelligence, clinical research, and commercial analytics. Cogvio operates as 'an IQVIA business,' and IQVIA itself sells broader market access and pricing analytics solutions, making it the closest incumbent for comparability on category, customer base, and commercial reach.

TypeDirect peer
Description

Life sciences consulting practice offering pricing, market access, and commercial analytics to pharma. Comparable to Cogvio on combining analytics, pricing expertise, and Big Pharma customer base.

TypeBroad incumbent
Description

Owns the former DRG market access and pricing intelligence franchise used by pharma for global pricing benchmarks, HTA, and forecasting. A direct competitor in international reference pricing and market access data, with broader portfolio scale.

TypeEmerging player
Description

Healthcare commercial intelligence provider selling analytics on providers, payers, and biopharma to life sciences customers. Partial overlap with Cogvio on pharma market intelligence use cases, though broader in scope.

TypeDirect peer
Description

Pharma strategy and analytics firm providing market access, pricing, and competitive intelligence to manufacturers. Comparable to Cogvio on customer base (Big Pharma) and on combining software-style insights with consulting services.

TypeRegional player
Description

Through PharmaLex and consulting arms, provides global market access, pricing, and regulatory services to pharma. Comparable in offering integrated market access and pricing expertise to manufacturers, with broader distribution/scale.

TypeDirect peer
Description

Specialty pharma commercial services firm offering pricing, market access, and data-driven launch solutions to manufacturers. Directly comparable to Cogvio's pricing/market access focus and enterprise pharma customer base, with both subscription software and consulting revenue streams.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses2 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cogvio

Pharmaceutical Market Access & Pricing Analyticscogvio.com

Cogvio, an IQVIA business, is a Prague-based SaaS and consulting provider that builds AI-powered pricing, market access and market intelligence tools for large pharmaceutical companies, serving clients such as AbbVie, Amgen, Biogen, Boehringer Ingelheim, MSD, Novartis and Pfizer.

What Cogvio does

Cogvio (legal entity Cogvio, s.r.o.) is a Prague-headquartered technology and data science company that develops SaaS products and provides consulting services to the pharmaceutical and healthcare industries. It operates as a wholly-owned subsidiary of IQVIA (NYSE:IQV) and is commercially positioned as 'COGVIO, an IQVIA business.' The company's product portfolio is built around three core SaaS tools: Price Monitor, an AI-powered platform that continuously integrates pricing, reimbursement and health technology assessment (HTA) data from more than 100 global sources to support market access, payer negotiations and lifecycle price management; Market Access Monitor, which tracks market access conditions across geographies; and Market Intelligence Tool, which provides competitive and market intelligence for pharma decision-makers. Underlying technology uses AI-powered algorithms for automatic data extraction, predictive analytics, optimization of launch and pricing strategies, and anomaly detection for price erosion control, complemented by custom analytics, real-world evidence (RWE) work, and integration with client data warehouses and BI systems.

Cogvio's commercial model combines annual subscription-based SaaS access to Price Monitor, Market Access Monitor and Market Intelligence Tool with a professional services arm that delivers custom consulting, audits, IT technology assessment, and GAMP/GDPR/HIPAA-compliant healthcare software development. Go-to-market is enterprise field sales targeting market access and pricing teams at large pharmaceutical companies; pricing is quote-based with no public tiers, and products are accessed via authenticated portals (pricemonitor.cogvio.com, login.cogvio.com, mit.cogvio.com). The named customer base includes seven top-tier pharmaceutical companies — AbbVie, Amgen, Biogen, Boehringer Ingelheim, MSD, Novartis and Pfizer — alongside a secondary healthcare IT segment serving hospitals and other organizations needing regulatory-compliant software. Cogvio was founded in 2017 by Pavel Svítil (CEO), Tomáš Doležal (Chief Knowledge Officer) and Petr Bartoš (CTO), combines deep regulatory, medical, pharmacoeconomics and software expertise, and is currently sized at 11-50 employees operating globally with particular concentration in Europe.

Cogvio firmographics

Firmographics
Name
Cogvio
Legal name
Cogvio, s.r.o.
Website
https://cogvio.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Cogvio, an IQVIA business, is a Prague-based SaaS and consulting provider that builds AI-powered pricing, market access and market intelligence tools for large pharmaceutical companies, serving clients such as AbbVie, Amgen, Biogen, Boehringer Ingelheim, MSD, Novartis and Pfizer.
Ownership category
akta.pro rank

Cogvio industry classification

Industry
Product category
Pharmaceutical Market Access & Pricing Analytics
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAIAKAK
Pricing Operations & Analytics (Price Governance, Systems, Reporting)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIAKAF
International Reference Pricing (IRP) & External Price Benchmarking
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIAKAA
Pricing & Contracting Strategy
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Pharmaceutical pricing analytics
  • Market access intelligence
  • Drug reimbursement data
  • Pharma SaaS platform
  • Healthcare data integration

Where Cogvio is headquartered

Location

Headquarters

HQ city
Prague
HQ country
Czechia
HQ region
Europe

Offices1 record

Markets served

Cogvio business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Products (SaaS): Subscription-based access to AI-powered software tools including Price Monitor, Market Access Monitor, and Market Intelligence Tool. These platforms provide continuous insights and analytics for pharmaceutical pricing and market access teams.
  2. Professional Services & Consulting: Custom consulting projects including tailor-made solutions, audits, IT technology assessment, and software development for pharma and healthcare clients. Cooperation model described as 'Be a partner, not a client.'

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise pricing via direct inquiry

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Cogvio product offering

Product offering

Core offering

Cogvio develops and sells AI-powered SaaS platforms—primarily Price Monitor—that aggregate over 100 global sources of drug pricing, reimbursement, and HTA data to deliver market access and pricing insights to pharmaceutical companies. Its offering is complemented by Market Access Monitor and Market Intelligence Tool, plus consulting and custom data analysis services for pharma and healthcare clients.

Product overview

COGVIO, an IQVIA business, is a technology start-up developing specialized software products and providing consulting to the pharma industry. The product portfolio centers on three main digital tools: Price Monitor (AI-powered pricing/reimbursement data platform integrating 100+ global sources), Market Access Monitor (market access monitoring), and Market Intelligence Tool (market intelligence). These are complemented by consulting services including drug pricing & market access strategies, advanced data analysis (custom projects, RWE analysis, data integration), and pharma/healthcare software development & compliance services.

Differentiator

Problem solved

Functional benefit

Brands

  • Price Monitor: AI-powered digital tool that integrates 100+ global sources of pricing/reimbursement/HTA data and provides market access and pricing insights for pharmaceutical companies.
  • Market Access Monitor
  • Market Intelligence Tool

Quantifiable outcome

  • AI-powered engine continuously integrating 100+ global data sources

Companies that use Cogvio

Customer profile

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Cogvio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Cogvio partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Cogvio competitors and assessment

Company assessment

Emerging players

  • OptimizeRx: Digital health platform providing market access, affordability, and physician-engagement solutions to pharma. Comparable in targeting pharma market access teams with software-based solutions, though more focused on patient affordability.
  • Definitive Healthcare: Healthcare commercial intelligence provider selling analytics on providers, payers, and biopharma to life sciences customers. Partial overlap with Cogvio on pharma market intelligence use cases, though broader in scope.

Broad incumbents

  • Veeva Systems: Dominant cloud platform vendor for pharma commercial and R&D workflows, including CRM and data products. Adjacent/competing for the same market access and pricing IT wallet with broader product breadth.
  • IQVIA: Parent company and global leader in healthcare intelligence, clinical research, and commercial analytics. Cogvio operates as 'an IQVIA business,' and IQVIA itself sells broader market access and pricing analytics solutions, making it the closest incumbent for comparability on category, customer base, and commercial reach.
  • Clarivate (Decision Resources Group): Owns the former DRG market access and pricing intelligence franchise used by pharma for global pricing benchmarks, HTA, and forecasting. A direct competitor in international reference pricing and market access data, with broader portfolio scale.

Direct peers

  • ZS Associates: Management consulting and analytics firm serving pharma with pricing, market access, and AI-driven commercial solutions. Comparable to Cogvio in domain specialization, enterprise pharma customers, and analytics-plus-services model.
  • Charles River Associates: Life sciences consulting practice offering pricing, market access, and commercial analytics to pharma. Comparable to Cogvio on combining analytics, pricing expertise, and Big Pharma customer base.
  • Trinity Life Sciences: Pharma strategy and analytics firm providing market access, pricing, and competitive intelligence to manufacturers. Comparable to Cogvio on customer base (Big Pharma) and on combining software-style insights with consulting services.
  • EVERSANA: Specialty pharma commercial services firm offering pricing, market access, and data-driven launch solutions to manufacturers. Directly comparable to Cogvio's pricing/market access focus and enterprise pharma customer base, with both subscription software and consulting revenue streams.

Regional players

  • Cencora (formerly AmerisourceBergen) / PharmaLex: Through PharmaLex and consulting arms, provides global market access, pricing, and regulatory services to pharma. Comparable in offering integrated market access and pricing expertise to manufacturers, with broader distribution/scale.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Cogvio social profiles

Digital presence

Cogvio compliance and trust

Trust signal

Compliance3 records

Cogvio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cogvio leadership team

Management profile

Number of profiles

Profiles3 records

Cogvio funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cogvio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cogvio

What does Cogvio do?

Cogvio develops and sells AI-powered SaaS platforms—primarily Price Monitor—that aggregate over 100 global sources of drug pricing, reimbursement, and HTA data to deliver market access and pricing insights to pharmaceutical companies. Its offering is complemented by Market Access Monitor and Market Intelligence Tool, plus consulting and custom data analysis services for pharma and healthcare clients.

Is Cogvio a public or private company?

Cogvio is a private company. It is classified as corporate owned and is currently operating.

When was Cogvio founded?

Cogvio was founded in 2017. It employs 11 to 50 people.

Where is Cogvio based?

Cogvio is headquartered in Prague, Czechia, in the Europe region.

How does Cogvio make money?

Two revenue lines are on record. Software Products (SaaS) is the primary driver. The others are professional Services & Consulting.

Who are Cogvio's main competitors?

Emerging players on record are OptimizeRx and Definitive Healthcare. Broad incumbents are Veeva Systems, IQVIA and Clarivate (Decision Resources Group). Direct peers are ZS Associates, Charles River Associates, Trinity Life Sciences and EVERSANA. Cencora (formerly AmerisourceBergen) / PharmaLex is listed as a regional player.

Does Cogvio have an API?

No public API is recorded for Cogvio.

What industry is Cogvio in?

Cogvio's product category is Pharmaceutical Market Access & Pricing Analytics. Its primary akta.pro industry code is HLAIAKAK, Pricing Operations & Analytics (Price Governance, Systems, Reporting), with a secondary code of HLAIAKAF, International Reference Pricing (IRP) & External Price Benchmarking. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales